A multi-organ metabolomics atlas reveals molecular dysregulations in Alzheimer's disease mouse models.
Document Type
Article
Publication Date
6-17-2026
Publication Title
Cell reports
Abstract
The etiology of Alzheimer's disease (AD) remains unclear but is likely driven by gene-environment interactions. We present a multi-organ untargeted metabolomics atlas (n = 2,271) paired with metagenomics data (n = 666) from two AD transgenic mouse models (3xTg and 5xFAD) under colonized and germ-free conditions. Systems-level analyses revealed clusters of dysregulated molecules across tissues, including carnitines, bile acids, B vitamins, neurotransmitters, and N-acyl lipids. Metabolic shifts were associated with the depletion of Akkermansia muciniphila and enrichment of Mucispirillum schaedleri in the 3xTg model. We identify previously unexplored carnitines linked to microbial metabolism of phenylalanine. Using tissueMASST-a mass spectrometry search tool we developed to translate animal-model findings into a human clinical context-we trace phenylacetyl-carnitine in human plasma and serum samples (n = 1,470) from independent cohorts, revealing associations with aging, cognitive impairment, and diminished memory performance. This public resource and associated tools will aid future research in AD etiology.
Volume
45
Issue
6
First Page
117499
Recommended Citation
Zuffa S, Allaband C, Charron-Lamoureux V, Caraballo-Rodriguez AM, Patan A, Mohanty I et al [Graham SF] A multi-organ metabolomics atlas reveals molecular dysregulations in Alzheimer's disease mouse models. Cell Rep. 2026 Jun 17;45(6):117499. doi: 10.1016/j.celrep.2026.117499. Epub ahead of print. PMID: 42308105.
DOI
10.1016/j.celrep.2026.117499
ISSN
2211-1247
PubMed ID
42308105